BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 12145019)

  • 1. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements.
    McNulty H; McKinley MC; Wilson B; McPartlin J; Strain JJ; Weir DG; Scott JM
    Am J Clin Nutr; 2002 Aug; 76(2):436-41. PubMed ID: 12145019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype.
    Moat SJ; Ashfield-Watt PA; Powers HJ; Newcombe RG; McDowell IF
    Clin Chem; 2003 Feb; 49(2):295-302. PubMed ID: 12560354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene.
    Jacques PF; Kalmbach R; Bagley PJ; Russo GT; Rogers G; Wilson PW; Rosenberg IH; Selhub J
    J Nutr; 2002 Feb; 132(2):283-8. PubMed ID: 11823591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the methylenetetrahydrofolate reductase 677C-->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample.
    de Bree A; Verschuren WM; Bjørke-Monsen AL; van der Put NM; Heil SG; Trijbels FJ; Blom HJ
    Am J Clin Nutr; 2003 Mar; 77(3):687-93. PubMed ID: 12600862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism.
    Hustad S; Ueland PM; Vollset SE; Zhang Y; Bjørke-Monsen AL; Schneede J
    Clin Chem; 2000 Aug; 46(8 Pt 1):1065-71. PubMed ID: 10926884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylenetetrahydrofolate reductase 677C-->T variant modulates folate status response to controlled folate intakes in young women.
    Guinotte CL; Burns MG; Axume JA; Hata H; Urrutia TF; Alamilla A; McCabe D; Singgih A; Cogger EA; Caudill MA
    J Nutr; 2003 May; 133(5):1272-80. PubMed ID: 12730409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial.
    Ashfield-Watt PA; Pullin CH; Whiting JM; Clark ZE; Moat SJ; Newcombe RG; Burr ML; Lewis MJ; Powers HJ; McDowell IF
    Am J Clin Nutr; 2002 Jul; 76(1):180-6. PubMed ID: 12081832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The methylenetetrahydrofolate reductase 677C-->T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism.
    Hustad S; Midttun Ø; Schneede J; Vollset SE; Grotmol T; Ueland PM
    Am J Hum Genet; 2007 May; 80(5):846-55. PubMed ID: 17436239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
    Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
    Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
    Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications.
    Mahmud N; Molloy A; McPartlin J; Corbally R; Whitehead AS; Scott JM; Weir DG
    Gut; 1999 Sep; 45(3):389-94. PubMed ID: 10446107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.
    Verhoef P; Kok FJ; Kluijtmans LA; Blom HJ; Refsum H; Ueland PM; Kruyssen DA
    Atherosclerosis; 1997 Jul; 132(1):105-13. PubMed ID: 9247365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients.
    Födinger M; Buchmayer H; Heinz G; Papagiannopoulos M; Kletzmayr J; Perschl A; Vychytil A; Hörl WH; Sunder-Plassmann G
    Am J Kidney Dis; 2001 Jul; 38(1):77-84. PubMed ID: 11431185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of T alleles and TT genotype at MTHFR 677C->T locus or C alleles and CC genotype at MTHFR 1298A->C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference intervals.
    Ozarda Y; Sucu DK; Hizli B; Aslan D
    Cell Biochem Funct; 2009 Dec; 27(8):568-77. PubMed ID: 19764044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenetetrahydrofolate reductase mutation (677C-->T) negatively influences plasma homocysteine response to marginal folate intake in elderly women.
    Kauwell GP; Wilsky CE; Cerda JJ; Herrlinger-Garcia K; Hutson AD; Theriaque DW; Boddie A; Rampersaud GC; Bailey LB
    Metabolism; 2000 Nov; 49(11):1440-3. PubMed ID: 11092508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project.
    Meleady R; Ueland PM; Blom H; Whitehead AS; Refsum H; Daly LE; Vollset SE; Donohue C; Giesendorf B; Graham IM; Ulvik A; Zhang Y; Bjorke Monsen AL;
    Am J Clin Nutr; 2003 Jan; 77(1):63-70. PubMed ID: 12499324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort.
    Chango A; Potier De Courcy G; Boisson F; Guilland JC; Barbé F; Perrin MO; Christidès JP; Rabhi K; Pfister M; Galan P; Hercberg S; Nicolas JP
    Br J Nutr; 2000 Dec; 84(6):891-6. PubMed ID: 11177206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic expression of the methylenetetrahydrofolate reductase 677C-->T polymorphism and flavin cofactor availability in thyroid dysfunction.
    Hustad S; Nedrebø BG; Ueland PM; Schneede J; Vollset SE; Ulvik A; Lien EA
    Am J Clin Nutr; 2004 Oct; 80(4):1050-7. PubMed ID: 15447919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of MTHFR 1298A-->C and MTHFR 677C-->T genotypes on total homocysteine, folate, and vitamin B(12) plasma concentrations in kdiney graft recipients.
    Födinger M; Buchmayer H; Heinz G; Papagiannopoulos M; Kletzmayr J; Rasoul-Rockenschaub S; Hörl WH; Sunder-Plassmann G
    J Am Soc Nephrol; 2000 Oct; 11(10):1918-1925. PubMed ID: 11004224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.